相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protein tyrosine phosphatase receptor type C (PTPRC or CD45)
Maryam Ahmed Al Barashdi et al.
JOURNAL OF CLINICAL PATHOLOGY (2021)
EGR1-mediated linc01503 promotes cell cycle progression and tumorigenesis in gastric cancer
Zhonghua Ma et al.
CELL PROLIFERATION (2021)
The phosphatase PAC1 acts as a T cell suppressor and attenuates host antitumor immunity
Dan Lu et al.
NATURE IMMUNOLOGY (2020)
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer
Eri Sugiyama et al.
SCIENCE IMMUNOLOGY (2020)
IFN-Stimulated Gene 15 Is an Alarmin that Boosts the CTL Response via an Innate, NK Cell-Dependent Route
Victoria Iglesias-Guimarais et al.
JOURNAL OF IMMUNOLOGY (2020)
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Elizabeth A. Mittendorf et al.
LANCET (2020)
Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer
Sangeetha M. Reddy et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Denarda Dangaj et al.
CANCER CELL (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients
Ryan J. Sullivan et al.
NATURE MEDICINE (2019)
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
Antoni Ribas et al.
NATURE MEDICINE (2019)
EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis
Lechen Li et al.
ONCOGENE (2019)
Dimensionality reduction for visualizing single-cell data using UMAP
Etienne Becht et al.
NATURE BIOTECHNOLOGY (2019)
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Masoud F. Tavazoie et al.
CELL (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Lamin A/C augments Th1 differentiation and response against vaccinia virus and Leishmania major
Raquel Toribio-Fernandez et al.
CELL DEATH & DISEASE (2018)
EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma
Trefa Mohamad et al.
Oncotarget (2018)
Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer
Naoko Matsuda et al.
JAMA ONCOLOGY (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients
Marc Van den Eynde et al.
CANCER CELL (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou et al.
CANCER DISCOVERY (2017)
S100A7: from mechanism to cancer therapy
L. Padilla et al.
ONCOGENE (2017)
EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
Xiaoping Wang et al.
Oncotarget (2017)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models
Adam R. Wolfe et al.
ONCOTARGET (2016)
Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling
Steven G. Allen et al.
SCIENTIFIC REPORTS (2016)
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker et al.
NATURE REVIEWS CANCER (2016)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Scott N. Gettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber et al.
LANCET ONCOLOGY (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a pre-clinical model
Lara Lacerda et al.
BREAST CANCER RESEARCH (2015)
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes
H. Masuda et al.
ANNALS OF ONCOLOGY (2014)
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival
F. Bertucci et al.
ANNALS OF ONCOLOGY (2014)
Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients
Isabel Sicking et al.
BMC CANCER (2014)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
CCL20/CCR6-mediated migration of regulatory T cells to the Helicobacter pylori-infected human gastric mucosa
Katherine W. Cook et al.
GUT (2014)
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Steven L. Highfill et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Nuclear envelope lamin-A as a coordinator of T cell activation
Vera Rocha-Perugini et al.
NUCLEUS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer through Activation of Axl Kinase
Xiaoping Wang et al.
CANCER RESEARCH (2013)
Diurnal redistribution of human lymphocytes and their temporal associations with salivary cortisol
Slavena T. Trifonova et al.
CHRONOBIOLOGY INTERNATIONAL (2013)
Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
Steven J. Van Laere et al.
CLINICAL CANCER RESEARCH (2013)
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
Alexander M. Lesokhin et al.
CANCER RESEARCH (2012)
Inflammatory Breast Cancer: What We Know and What We Need to Learn
Hideko Yamauchi et al.
ONCOLOGIST (2012)
Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal Neutrophils
Zvi G. Fridlender et al.
PLOS ONE (2012)
Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency
Dusan Bogunovic et al.
SCIENCE (2012)
Humanized mice for immune system investigation: progress, promise and challenges
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2012)
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
S. Dawood et al.
ANNALS OF ONCOLOGY (2011)
inSilicoDb: an R/Bioconductor package for accessing human Affymetrix expert-curated datasets from GEO
Jonatan Taminau et al.
BIOINFORMATICS (2011)
Differences in Survival Among Women With Stage III Inflammatory and Noninflammatory Locally Advanced Breast Cancer Appear Early A Large Population-Based Study
Shaheenah Dawood et al.
CANCER (2011)
Regulation of effector and memory T-cell functions by type I interferon
Jonathan P. Huber et al.
IMMUNOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
CXCL5 Regulates Chemokine Scavenging and Pulmonary Host Defense to Bacterial Infection
Junjie Mei et al.
IMMUNITY (2010)
EGR1 reactivation by histone deacetylase inhibitors promotes synovial sarcoma cell death through the PTEN tumor suppressor
L. Su et al.
ONCOGENE (2010)
Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice
Leonard D. Shultz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
B. Corkery et al.
ANNALS OF ONCOLOGY (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Early growth response genes regulate B cell development, proliferation, and immune response
Murali Gururajan et al.
JOURNAL OF IMMUNOLOGY (2008)
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer
N. Cabioglu et al.
ANNALS OF ONCOLOGY (2007)
Adjusting batch effects in microarray expression data using empirical Bayes methods
W. Evan Johnson et al.
BIOSTATISTICS (2007)
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
F Ishikawa et al.
BLOOD (2005)
Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute
KW Hance et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Molecular profiling of inflammatory breast cancer:: Identification of a poor-prognosis gene expression signature
I Bièche et al.
CLINICAL CANCER RESEARCH (2004)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Update on the management of inflammatory breast cancer
M Cristofanilli et al.
ONCOLOGIST (2003)
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
L Monney et al.
NATURE (2002)
分享论文
